Skip to main content

Clover Health Investments, Corp 10-Q for FY2026 Q3

Clover Health Investments, Corp. (CLOV)

10-Q 2026-11-06 For: 2026-09-30
View Original
Added on November 06, 2026

About this 10-Q

Clover Health Investments, Corp filed this 10-Q on November 6, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Clover Health Investments, Corp. reported nine-month revenue of $2,251.7 million, up 57%, and net income of $61.8 million versus prior-year losses. Adjusted EBITDA rose to $97.2 million, while cash, cash equivalents, and investments totaled $512.6 million at September 30, 2026. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$759.3M
up 52.9% from $496.65M a year earlier
Net income
$6.44M
compared with a net loss of $24.38M a year earlier
Diluted EPS
$0.01
compared with -$0.05 a year earlier